Skip to main content
. 2021 Dec 16;5(24):5479–5489. doi: 10.1182/bloodadvances.2021004530

Figure 2.

Figure 2.

Survival analysis for patients with TA-TMA. No significant difference was observed in overall survival between the derivation cohort and the validation cohort.